Navigation Links
OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)

Prestigious Awards Recognize Excellence in New Product Development, Marketing and Innovation

BEDFORD, Mass., Feb. 11 /PRNewswire-FirstCall/ -- The OmniPod(R) Insulin Management System, designed and produced by Insulet Corporation (Nasdaq: PODD), has been selected as a finalist for the prestigious 2009 Edison Best New Product AwardsTM. The awards are among the most elite accolades honoring excellence in new product development, marketing, and innovation. Strategic implementation partners for the 2009 awards program include the Thomas Edison Papers at Rutgers University, the Marketing Executives Networking Group (MENG) and The MIT/Stanford Venture Lab (VLAB).

The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. The OmniPod System offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod - a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager - a wireless, menu-driven, hand-held device that programs the Pod.

The Edison Best New Product Awards, sponsored this year by Google, The Nielsen Company and Steelcase, focus on new products and services that excel in marketplace innovation, marketplace success, technological innovation, market structure innovation, and societal impact. These criteria align with Edison's own innovation best practices, called the Five Competencies of Innovation. MENG members nationwide cast their ballots for entries they deemed worthy of being linked to the Edison name.

"We are honored that the OmniPod System has been recognized for its innovative design and the positive impact it has on the lives of people with diabetes," said Duane DeSisto, president and CEO of Insulet Corporation. "When we created the OmniPod, we started with a blank slate and took a customer-centric approach to designing a new insulin delivery system. Its tubing-free, wireless design makes it totally discreet and the Pod is watertight and durable enough to be worn by many professional athletes. The OmniPod's automated, virtually pain-free insertion means customers never see or handle an insertion needle."

"Innovative, collaborative, passionate, and persistent are just a few of the many characteristics that describe the finalists for the 2009 Edison Best New Product Awards," stated Sarah Miller Caldicott, great grandniece of Thomas Edison, co-author of Innovate Like Edison and Chairperson of the Edison Awards Steering Committee. "All of our 2009 finalists, each in different ways, exemplify the very best in innovation."

Gold, Silver and Bronze winners will be announced at an Awards Gala on April 1, 2009 at the Computer History Museum in Mountain View, California. To register to attend, visit

About The Edison Awards:

The Edison Best New Products Award(TM) recognizes the persistence and excellence Thomas Edison personified, qualities which have allowed America to remain in the forefront of innovation, creativity, and ingenuity in the global economy. The Edison Achievement Award(TM) honors business leaders who have displayed the persistence, collaboration, and creativity necessary to promote successful innovation in their organizations. For more information about The Edison Awards, visit

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Media Contacts:
    Mark Sahl on behalf of Insulet

    Chris Faust on behalf of The Edison Awards

SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R)
2. Insulin May Protect Against Alzheimers
3. Intensive Insulin Therapy Reduces Mortality in Sick Kids
4. High insulin levels raise risk of breast cancer in postmenopausal women
5. High Insulin May Boost Odds of Breast Cancer
6. Vitamin K Slows Insulin Resistance in Older Men
7. Vitamin K linked to insulin resistance in older men
8. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
9. Completely novel action of insulin unveiled
10. Impact of insulin pump under study
11. Diabetes Spectrum Reports a Study Assessing the i-port(R) Injection Port for Administration of Insulin
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: